exo-tert-Butyl 3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate acetate

Catalog No. :
ACIYKS679
CAS No. :
2007910-58-7
Molecular Formula :
C14H26N2O4
Molecular Weight :
286.37

IUPAC Name:tert-butyl (1R,3s,5S)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate acetate

exo-tert-Butyl 3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$82.00Login to see priceIn stockInquiry
10g97%$136.00Login to see priceIn stockInquiry
25g97%$292.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nameexo-tert-Butyl 3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate acetate
IUPAC Nametert-butyl (1R,3s,5S)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate acetate
MDL No.MFCD30471659
Molecular FormulaC14H26N2O4
Molecular Weight286.37
SMILESO=C(N1[C@@H]2C[C@H](N)C[C@H]1CC2)OC(C)(C)C.CC(O)=O
InChI KeyMGOGAGPPPDSADC-FKMGVRPPSA-N
Synonymexo-3-amino-8-boc-8-azabicyclo[3.2.1]octane acetate;8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-amino-, 1,1-dimethylethyl ester, acetate (1:1), (3-exo)-;tert-butyl Rel-(1r,3r,5s)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate acetate
CAS No.2007910-58-7
PubChem CID127263577

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIYKS679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIYKS679 route product structure diagram
    ACIYKS6792007910-58-7 In Stock
Inquiry

2. ACIYKS679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIYKS679 route product structure diagram
    ACIYKS6792007910-58-7 In Stock
Inquiry

Comments (0)